Last reviewed · How we verify

NCT07489794: MS-UI-PFM

URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS

Recruiting now Last updated 24 March 2026
What this trial tests

trial in Multiple Sclerosis in 47 participants. Currently enrolling.

Timeline
9 March 2026
Primary endpoint
20 September 2026
30 October 2026

Quick facts

Lead sponsorProf. Dr. Cemil Tascıoglu Education and Research Hospital Organization
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment47
Start date9 March 2026
Primary completion20 September 2026
Estimated completion30 October 2026
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Who can join

Adults 30 to 50, female only, with Multiple Sclerosis or Urinary Incontinence (UI). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the relationship between urinary incontinence severity and surface electromyography (EMG) findings in women with multiple sclerosis. It will also examine the association of urinary incontinence with disability, quality of life, physical activity, and fatigue.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07489794.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing